Jd. Winkler et al., EFFECTS OF COA-INDEPENDENT TRANSACYLASE INHIBITORS ON THE PRODUCTION OF LIPID INFLAMMATORY MEDIATORS, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1338-1347
The enzyme CoA-independent transacylase (CoA-IT) has been proposed to
mediate the movement of arachidonate between specific phospholipid sub
classes, and we have shown that two inhibitors of CoA-IT (SK&F 98625 a
nd SK&F 45905) block this movement. In this report, we use these inhib
itors to further characterize the role of CoA-IT in the production of
lipid mediators. SK&F 98625 (diethyl oxo-2,3-dihydro-imidazol-1-yl)hep
tane-phosphonate) and SK&F 45905 -3-trifluoromethylphenyl)ureido]-4-tr
ifluoromethyl phenoxy]-4,5-dichlorobenzenesulfonic acid) inhibited CoA
-IT activity (IC50 values of 9 mu M and 6 mu M, respectively). Neither
compound had any effect on cyclooxygenase, 14-kDa PLA(2) or acetyltra
nsferase activities at concentrations below 20 mu M. However, SK&F 459
05 inhibited 85-kDa PLA, activity (IC50 = 3 mu M), and both compounds
inhibited 5-lipoxygenase activity (IC50 values of 2-4 mu M). In ionoph
ore-stimulated neutrophils, SK&F 98625 and SK&F 45905 blocked the libe
ration of arachidonic acid from phospholipids, which suggests that the
movement of arachidonate into specific phospholipid pools is a prereq
uisite for release. Both compounds also inhibited the production of pl
atelet-activating factor in ionophore-stimulated neutrophils and antig
en-stimulated mast cells. This inhibition of platelet-activating facto
r and arachidonic acid release was not mimicked by an inhibitor of 5-l
ipoxygenase, zileuton, which indicates that the primary mode of action
of SK&F 98625 and SK&F 45905 is via inhibition of CoA-IT. SK&F 98625
and SK&F 45905 were able to decrease prostaglandin production in sever
al inflammatory cells and to block signs of inflammation in ears of ph
orbol ester-challenged mice. Taken together, these results show that b
lockade of CoA-IT, which leads to inhibition of arachidonate remodelin
g between phospholipids, results in the attenuation of platelet-activa
ting factor production, arachidonic acid release and the formation of
eicosanoid products.